Tilman D. Rachner - Concepedia

Author

Tilman D. Rachner

Also Known As

Rachner, Tilman Daniel, T D Rachner, T Rachner, T. D. Rachner, T. Rachner, T.D. Rachner, T.D. Rachner⁎, Tilman D Rachner, Tilman D. Rachner, Tilman Rachner

122

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

Technische Universität Dresden Heidelberg University Philipps University of Marburg German Cancer Research Center University of Würzburg

About

Tilman D. Rachner is an author at Technische Universität Dresden specializing in medicine, breast cancer, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	507
2	Cell Biology	9	9	303
3	Health Sciences	2	2	50
4	Natural Sciences	2	2	35
5	Biochemistry	1	1	23

Tilman D. Rachner

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells Andy Göbel, Dorit Breining, Martina Rauner, Cell Death and Disease	2019	112
The effect of the degree of sulfation of glycosaminoglycans on osteoclast function and signaling pathways Juliane Salbach‐Hirsch, Stefanie Kliemt, Martina Rauner, Biomaterials MechanobiologyOsteoclast FunctionGlycobiologySignaling PathwaysOsteoarthritis	2012	82
High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients Tilman D. Rachner, Stefanie Thiele, Andy Göbel, BMC Cancer	2014	71
Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells Tilman D. Rachner, Shiv K. Singh, Michael Schoppet, Cancer Letters Breast OncologyTrail/opg RatioMedicineApoptosisPharmacology	2009	62
Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells Andy Göbel, Stefanie Thiele, Andrew Browne, Cancer Letters Zoledronic AcidBreast OncologyMedicinePharmacologyMevalonate Pathway	2016	58
Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates Sylvia Thiele, Martina Rauner, Claudia Goettsch, Journal of Cellular Biochemistry SclerostinPathologyExpression ProfileSerum SamplesOsteoporosis	2011	56
p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells Andrew Browne, Andy Göbel, Stefanie Thiele, Cell Death and Disease	2016	50
Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer Andy Göbel, Valentina M. Zinna, S. Dell'Endice, BMC Cancer	2020	49
Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification Belinda A. Di Bartolo, Michael Schoppet, Mohamed Abdelbari Mattar, Cardiovascular Research	2011	45
WNT5A Has Anti-Prostate Cancer Effects In Vitro and Reduces Tumor Growth in the Skeleton In Vivo Stefanie Thiele, Andy Göbel, Tilman D. Rachner, Journal of Bone and Mineral Research	2014	45

Page 1